VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,801 | -36.0% | 7,016 | -28.4% | 0.06% | -32.1% |
| Q2 2023 | $295,229 | -11.3% | 9,805 | -4.7% | 0.08% | -16.0% |
| Q1 2023 | $332,849 | +92874.6% | 10,289 | -17.6% | 0.10% | -7.4% |
| Q4 2022 | $358 | -99.9% | 12,490 | -37.8% | 0.11% | -28.5% |
| Q3 2022 | $484,000 | -57.0% | 20,079 | -51.2% | 0.15% | -53.7% |
| Q2 2022 | $1,126,000 | -31.0% | 41,118 | -3.4% | 0.33% | -17.9% |
| Q1 2022 | $1,632,000 | +33.2% | 42,564 | +11.3% | 0.40% | +33.2% |
| Q4 2021 | $1,225,000 | -19.0% | 38,245 | -14.1% | 0.30% | -26.2% |
| Q3 2021 | $1,513,000 | 0.0% | 44,525 | 0.0% | 0.40% | 0.0% |
| Q2 2021 | $1,513,000 | – | 44,525 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |